3rd Asian Pacific Conference: Perspectives in Lung Cancer

11. 9. 2009 - 12. 9. 2009, Sheraton Grande Sukhumvit, Bangkok, Thailand

  • Témata:
  • Changes in lung cancer epidemiology in Asia
  • Lung cancer screening
  • Endoscopic ultrasongraphy for peripheral lung lesions
  • Maintenance therapy
  • Neo-adjuvant and adjuvant therapy for early stage NSCLC
  • Molecular targeted therapy in adjuvant treatment regimens
  • Stereotactic RT for early stage disease
  • VATS
  • Novel therapeutic targets
  • Personalized medicine
  • EGFR mutations and inhibition
  • Ethnic differences in lung cancer
  • Best of American Society of Clinical Oncology 2009 Annual Meeting: Localregional disease and
  • metastatic disease
  • Assessment of mediastinal involvement
  • Developments in small cell lung cancer
  • Management of bone metastasis
  • Biostatistics
  • Lung cancer study groups and research plan in Asia and the United States

Registrace

Friday, 11 September 2009
8:00 Welcome
Tony Mok, MD; Sumitra Thongprasert, MD

Session I: Introductory lectures
8:15 Lung cancer in Asia
Tony Mok, MD

9:00 Pathological results of lung cancer in Chiang Mai
Nirush Lertprasertsuk, MD, PhD

9:20 Lung cancer screening with spiral CT scan: Where are we?
Robert J. van Klaveren, MD, PhD

9:40 Coffee break

Session II: Surgery and staging
10:10 The new staging system for lung cancer
Pieter E. Postmus, MD, PhD

10:30 Utilization of CT scan, MRI and PET-CT for staging and monitoring of lung cancer
Juntima Eauthrongchit, MD

10:50 Minimally invasive techniques for staging the mediastinum
Stefano Gasparini, MD, FCCP

11:10 Endoscopic ultrasonography for peripheral lung lesion
Norihiko Ikeda, MD, PhD

11:30 Lunch break

Session III: Early stage disease
12:30 Neo-adjuvant and adjuvant therapy for early stage NSCLC
Giorgio V. Scagliotti, MD, PhD

12.50 The rationale and prospect of molecular targeted therapy in adjuvant therapy
Suresh S. Ramalingam, MD

13:10 Radiation therapy and stereotatic RT for early stage NSCLC
Guo-Liang Jiang, MD, FACR

13:30 VATS for primary resection and metastatectomy
Somchareon S. Saeteng, MD

14:00 Coffee break

Keynote lecture

14:30 Maintenance therapy: Yes or no
Suresh Ramalingam, MD

Session IV: Interactive case presentations
15:15 Case 1: Surgically-based case discussion
Somchareon Saeteng, MD

Case 2: Systemic treatment of advanced non-small cell lung cancer in Asia: Current evidence and practice
Gilberto de Lima Lopes, Jr., MD

Case 3: Tyrosine kinase inhibitor in non-small cell lung cancer
Virote Sriurangpong, MD

16:15 Adjourn

Saturday, 12 September 2009
8:00 Welcome
Giorgio V. Scagliotti, MD, PhD; Sumitra Thongprasert, MD

8:15 Keynote lecture: Monoclonal antibodies in NSCLC
Robert Pirker, MD

Session V: Translational research
9:00 Novel therapeutic targets in lung cancer
Tetsuya Mitsudomi, MD

9:20 Personalized medicine via molecular diagnostics
Giorgio V. Scagliotti, MD, PhD

9:40 EGFR mutations: Laboratory perspective versus clinical perspective Laboratory Angle: Speaker invited
Clinical Angle: Tony Mok, MD

10:10 An introduction to cancer epigenetics
Qian Tao, PhD

10:30 Coffee break

Session VI: Emerging data and clinical trial updates
11:00 EGFR inhibitors, angiogenesis inhibitors and tyrosine kinase inhibitors
Lu Shun, MD

11:30 Emerging new therapies in NSCLC: HDAC inhibitors, Hedgehog inhibitors, vaccines, TRAIL antibodies
Michael Boyer, MBBS, PhD, FRACP

12:00 Best of ASCO and IASLC 2009: Local-regional disease
Sumitra Thongprasert, MD

12:30 Best of ASCO and IASLC 2009: Metastatic disease
Tony Mok, MD

13:00 Lunch break

Session VII: Special topics in thoracic oncology
14:00 Novel agents and targets in anti-angiogenesis and anti-vascularization
Giorgio V. Scagliotti, MD, PhD

14:30 Small cell lung cancer
Pieter E. Postmus, MD, PhD

15:00 Areas of therapeutic neglect
Yi- Long Wu,MD

15:30 Coffee break

Session VIII: Lung cancer research methodology
15:50 Statistics for clinicians
Benny C. Y. Zee, PhD

16:10 Lung cancer study groups and research plan in the United States
Suresh S. Ramalingam, MD

16:30 Quality of life in lung cancer
Sumitra Thongprasert, MD

16:50 Adjourn

Kontakt: meetings@imedex.com

Web: http://www.imedex....ements/a088-01.asp

  • Sdílejte na:
    • Facebook
    • Twitter
    • Del.icio.us
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live